2021
Species distribution and antifungal susceptibility of Aspergillus clinical isolates in Lebanon
Osman M, Bidon B, Abboud C, Zakaria A, Hamze B, Achcar M, Mallat H, Dannaoui E, Dabboussi F, Papon N, Bouchara J, Hamze M. Species distribution and antifungal susceptibility of Aspergillus clinical isolates in Lebanon. Future Microbiology 2021, 16: 13-26. PMID: 33438473, DOI: 10.2217/fmb-2020-0141.Peer-Reviewed Original ResearchConceptsAntifungal susceptibilityAspergillus clinical isolatesAntifungal susceptibility patternsReverse transcription-quantitative PCRNational Reference CenterOverall drug resistanceTranscription-quantitative PCRInvasive mycosesSusceptibility patternsHealth strategiesEUCAST recommendationsReference centerClinical isolatesAmphotericin BDrug resistanceResistant isolatesMajor causeGene mutationsExpression levelsIsolatesEpidemiologySusceptibilityMycoses
2019
Recent trends in the epidemiology, diagnosis, treatment, and mechanisms of resistance in clinical Aspergillus species: A general review with a special focus on the Middle Eastern and North African region
Zakaria A, Osman M, Dabboussi F, Rafei R, Mallat H, Papon N, Bouchara J, Hamze M. Recent trends in the epidemiology, diagnosis, treatment, and mechanisms of resistance in clinical Aspergillus species: A general review with a special focus on the Middle Eastern and North African region. Journal Of Infection And Public Health 2019, 13: 1-10. PMID: 31672427, DOI: 10.1016/j.jiph.2019.08.007.Peer-Reviewed Original ResearchConceptsInfectious disease specialistsSuccessful treatment outcomeIndividual patient therapyAntifungal susceptibility patternsAvailable diagnostic toolsAspergillus sppDisease specialistsAspergillus infectionMechanisms of resistanceTreatment outcomesSusceptibility patternsEarly diagnosisPatient therapyHealth workforceFungal infectionsEpidemiological surveillanceHealth issuesAntifungal resistance mechanismsHealth careAntifungal resistanceAspergillosisPatientsDiagnostic toolInfectionEpidemiology